Please provide your email address to receive an email when new articles are posted on . Postmenopausal women with moderate to severe genitourinary syndrome experienced small but significant increases ...
Please provide your email address to receive an email when new articles are posted on . Researchers identified no link between vaginal estrogen tablet use and recurrent stroke risk. The findings did ...
A total of 3353 recurrent cases were identified from a cohort of 56,642 women with a first-time stroke and were matched with 3353 controls. HealthDay News — For women with a history of ischemic stroke ...
BAUDETTE, Minn., Sept. 12, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval for ...
Yaz (drospirenone/ethinyl estradiol) is a prescription oral tablet that’s used to help prevent pregnancy. It’s also used to treat acne and premenstrual dysphoric disorder in certain people. Yaz ...
Between 27 and 84% of postmenopausal women experience moderate to severe vaginal discomfort. This common discomfort can be remedied with local application of lubricants, moisturizers, or estrogen ...
NEW YORK (Reuters Health) - An ultra-low dose of 10 micrograms of estradiol significantly improves vaginal tissue, pH balance, and urogenital symptoms in postmenopausal women with vaginal atrophy, new ...
Exposure to vaginal estradiol not linked to increased rate of recurrent ischemic stroke when adjusted for comorbidity, medications, income, education. (HealthDay News) — For women with a history of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback